[Asia Economy Reporter Park Jihwan] Dongkook Pharmaceutical announced on the 1st that it has decided to split the par value per share from 2,500 won to 500 won to increase the number of outstanding shares.



The expected trading suspension period is from August 24 to September 9. The scheduled listing date for the new shares is set for September 10.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing